CLINICAL TRIALS PROFILE FOR COCAINE HYDROCHLORIDE
⮫ Send this page by email
✉ Email this page to a colleague
« Back to Dashboard
All Clinical Trials for COCAINE HYDROCHLORIDE
Trial ID
Title
Status
Sponsor
Phase
Start Date
Summary
NCT00000187 ↗ Ritanserin in Treatment of Cocaine Dependence - 1
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1992-07-01
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine
dependence.
NCT00000187 ↗ Ritanserin in Treatment of Cocaine Dependence - 1
Completed
University of Pennsylvania
Phase 2
1992-07-01
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine
dependence.
NCT00000188 ↗ Selegiline in Treatment of Cocaine Dependence - 2
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1994-09-01
The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine
dependence.
NCT00000188 ↗ Selegiline in Treatment of Cocaine Dependence - 2
Completed
University of Pennsylvania
Phase 2
1994-09-01
The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine
dependence.
NCT00000189 ↗ Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1990-01-01
The purpose of this study is to test antidepressant medication, gepirone, as a
pharmacotherapy for cocaine dependent subjects.
NCT00000189 ↗ Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
Completed
University of Pennsylvania
Phase 2
1990-01-01
The purpose of this study is to test antidepressant medication, gepirone, as a
pharmacotherapy for cocaine dependent subjects.
NCT00000191 ↗ Carbamazepine Treatment for Cocaine Dependence - 5
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1991-01-01
The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine
dependence.
>Trial ID
>Title
>Status
>Phase
>Start Date
>Summary
Clinical Trial Conditions for COCAINE HYDROCHLORIDE
Condition Name
Condition Name for COCAINE HYDROCHLORIDE
Intervention
Trials
Cocaine-Related Disorders
141
Cocaine Dependence
138
Cocaine Use Disorder
35
Cocaine Abuse
26
[disabled in preview]
0
Subscribe for full access, or try a Trial
Condition MeSH
Condition MeSH for COCAINE HYDROCHLORIDE
Intervention
Trials
Cocaine-Related Disorders
315
Disease
79
Substance-Related Disorders
55
Opioid-Related Disorders
40
[disabled in preview]
0
Subscribe for full access, or try a Trial
Clinical Trial Locations for COCAINE HYDROCHLORIDE
Trials by Country
Trials by Country for COCAINE HYDROCHLORIDE
Location
Trials
United States
526
Canada
11
Spain
9
Brazil
9
Switzerland
7
Subscribe for full access, or try a Trial
Trials by US State
Trials by US State for COCAINE HYDROCHLORIDE
Location
Trials
Texas
71
New York
52
Pennsylvania
52
Connecticut
47
California
40
Subscribe for full access, or try a Trial
Clinical Trial Progress for COCAINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Phase for COCAINE HYDROCHLORIDE
Clinical Trial Phase
Trials
Phase 4
29
Phase 3
30
Phase 2/Phase 3
17
[disabled in preview]
372
Subscribe for full access, or try a Trial
Clinical Trial Status
Clinical Trial Status for COCAINE HYDROCHLORIDE
Clinical Trial Phase
Trials
Completed
343
Recruiting
31
Terminated
30
[disabled in preview]
73
Subscribe for full access, or try a Trial
Clinical Trial Sponsors for COCAINE HYDROCHLORIDE
Sponsor Name
Sponsor Name for COCAINE HYDROCHLORIDE
Sponsor
Trials
National Institute on Drug Abuse (NIDA)
304
Yale University
49
New York State Psychiatric Institute
43
[disabled in preview]
96
Subscribe for full access, or try a Trial
Sponsor Type
Sponsor Type for COCAINE HYDROCHLORIDE
Sponsor
Trials
Other
550
NIH
319
Industry
43
[disabled in preview]
31
Subscribe for full access, or try a Trial
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
